Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Rapid Mobilization of Long Term Repopulating Hematopoietic Stem Cells (HSC) with AMD15057, a Small Molecule Inhibitor of VLA4; Synergism with AMD3100 and G-CSF

Pablo A. Ramirez, MD, Michael Rettig, PhD, Matthew Holt, Julie Ritchey, John F. DiPersio, MD, PhD

Blood (2008) 112 (11): 615.

https://doi.org/10.1182/blood.V112.11.615.615

Published: 2008

Journal Articles

Phenotypic and Functional Analysis of T-Cells Mobilized in HLA-Matched Sibling Donors Following Treatment with the Chemokine Antagonist AMD3100.

Michael Rettig, PhD, Steven M. Devine, MD, Julie Ritchey, John F. DiPersio, MD,PhD

Blood (2006) 108 (11): 3001.

https://doi.org/10.1182/blood.V108.11.3001.3001

Published: 2006

Journal Articles

Comparison of the Proliferative Kinetics, GVHD Potential and GCV Sensitivity of Naive and Transduced and Selected Murine T Cells after Allogeneic BMT.

Michael Rettig, PhD, Julie Ritchey, Julie Prior, David Piwnica-Worms, MD/PhD, Mark Bonyhadi, PhD, John DiPersio, MD/PhD.

Blood (2005) 106 (11): 5257.

https://doi.org/10.1182/blood.V106.11.5257.5257

Published: 2005

Journal Articles

Evaluation of the Phenotype and GVHD-Inducing Potential of Splenic T Cells Isolated from G-CSF, AMD3100, or G-CSF and AMD3100 Pretreated Allogeneic Donors.

Michael Rettig, PhD, Matthew Holt, Fulu Liu, MD, Julie Ritchey, Daniel Link, MD, Gary Bridger, PhD, John DiPersio, MD/PhD

Blood (2005) 106 (11): 5224.

https://doi.org/10.1182/blood.V106.11.5224.5224

Published: 2005

Journal Articles

A Murine Xenograft Model for Human T Cell Mediated Graft Versus Host Disease.

Bruno Nervi, MD, Michael Rettig, PhD, Julie Ritchey, Jon Walker, Gerhard Bauer, Phillip Herrbrich, Jan A. Nolta, PhD, John F. DiPersio, Md/PhD

Blood (2004) 104 (11): 4977.

https://doi.org/10.1182/blood.V104.11.4977.4977

Published: 2004

Journal Articles

In Vivo Suicide Gene Therapy of Human T Lymphocytes To Prevent Graft Versus Host Disease in a Murine Xenograft Model.

Bruno Nervi, MD, Michael Rettig, PhD, Julie Ritchey, Jon Walker, Gerhard Bauer, Philip Herrbrich, Mark L. Bonyhadi, PhD, Jan A. Nolta, PhD, John F. DiPersio, MD/PhD

Blood (2004) 104 (11): 4979.

https://doi.org/10.1182/blood.V104.11.4979.4979

Published: 2004

NARROW

Rapid Mobilization of Long Term Repopulating Hematopoietic Stem Cells (HSC) with AMD15057, a Small Molecule Inhibitor of VLA4; Synergism with AMD3100 and G-CSF

Phenotypic and Functional Analysis of T-Cells Mobilized in HLA-Matched Sibling Donors Following Treatment with the Chemokine Antagonist AMD3100.

Comparison of the Proliferative Kinetics, GVHD Potential and GCV Sensitivity of Naive and Transduced and Selected Murine T Cells after Allogeneic BMT.

Evaluation of the Phenotype and GVHD-Inducing Potential of Splenic T Cells Isolated from G-CSF, AMD3100, or G-CSF and AMD3100 Pretreated Allogeneic Donors.

A Murine Xenograft Model for Human T Cell Mediated Graft Versus Host Disease.

In Vivo Suicide Gene Therapy of Human T Lymphocytes To Prevent Graft Versus Host Disease in a Murine Xenograft Model.

Email alerts

ASH Publications

American Society of Hematology

Rapid Mobilization of Long Term Repopulating Hematopoietic Stem Cells (HSC) with AMD15057, a Small Molecule Inhibitor of VLA4; Synergism with AMD3100 and G-CSF

Phenotypic and Functional Analysis of T-Cells Mobilized in HLA-Matched Sibling Donors Following Treatment with the Chemokine Antagonist AMD3100.

Comparison of the Proliferative Kinetics, GVHD Potential and GCV Sensitivity of Naive and Transduced and Selected Murine T Cells after Allogeneic BMT.

Evaluation of the Phenotype and GVHD-Inducing Potential of Splenic T Cells Isolated from G-CSF, AMD3100, or G-CSF and AMD3100 Pretreated Allogeneic Donors.

A Murine Xenograft Model for Human T Cell Mediated Graft Versus Host Disease.

In Vivo Suicide Gene Therapy of Human T Lymphocytes To Prevent Graft Versus Host Disease in a Murine Xenograft Model.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only